Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis

被引:13
作者
Yoshida, Y
Hashimoto, N
Tokuyama, Y
Kitagawa, H
Takahashi, K
Yagui, K
Kanatsuka, A
Bujo, H
Higurashi, M
Miyazawa, S
Yoshida, S
Saito, Y
机构
[1] Asahi Gen Hosp, Dept Diabet & Metab Dis, Chiba 2892511, Japan
[2] Asahi Gen Hosp, Dept Immunol & Internal Med, Chiba 2892511, Japan
[3] Kasori Hosp, Ctr Diabet, Chiba, Japan
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2004年 / 53卷 / 09期
关键词
D O I
10.1016/j.metabol.2004.04.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated effects of weight loss from diet and exercise regimen in obese subjects with normal fasting plasma glucose or impaired glucose tolerance (IGT) on insulin release capacity and insulin sensitivity. Eight subjects were recruited among visceral obesity patients (4 men, 4 women; age range, 24 to 57 years; body mass index [BMI], 32.8 to 60.3 kg/m(2)). All were admitted to Chiba University Hospital for 2 weeks, were treated with a tapering 5,023 to 2,930 W diet, and were given exercise equivalent to 628 kJ/d. For assessments, we used a combination of C-peptide secretion rate determination and minimal model analysis as previously reported. BMI and visceral fat area (V) significantly decreased (BMI on initiation v after intervention, 43.0 +/- 3.2 v 40.3 +/- 3.1 kg/m(2), p < .05; V, 224 +/- 22 v 188 +/- 22 cm(2); P < .05). Fasting immunoreactive insulin (F-IRI) and leptin concentrations decreased significantly. Capacity for insulin release in response to glucose increased in all subjects (first-phase insulin secretion [CS1], 4.66 +/- 4.05 v 6.81 +/- 4.57 ng/mL/5 min, P < .05), but the insulin sensitivity index (Si) did not change significantly. These data suggest that weight reduction early in development of type 2 diabetes can oppose progression of diabetes by improving capacity for insulin release. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1095 / 1100
页数:6
相关论文
共 46 条
[1]   Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells) [J].
Ahrén, B ;
Havel, PJ .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1999, 277 (04) :R959-R966
[2]   Production of plasminogen activator inhibitor 1 by human adipose tissue - Possible link between visceral fat accumulation and vascular disease [J].
Alessi, MC ;
Peiretti, F ;
Morange, P ;
Henry, M ;
Nalbone, G ;
JuhanVague, I .
DIABETES, 1997, 46 (05) :860-867
[3]  
Bergman RN, 1979, AM J PHYSIOL, V236, P667
[4]   Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo [J].
Cases, JA ;
Gabriely, I ;
Ma, XH ;
Yang, XM ;
Michaeli, T ;
Fleischer, N ;
Rossetti, L ;
Barzilai, N .
DIABETES, 2001, 50 (02) :348-352
[5]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[6]   STIMULATION OF INSULIN SECRETION BY INFUSION OF FREE FATTY ACIDS [J].
CRESPIN, SR ;
GREENOUGH, WB ;
STEINBERG, D .
JOURNAL OF CLINICAL INVESTIGATION, 1969, 48 (10) :1934-+
[7]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[8]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[9]   PREHEPATIC INSULIN PRODUCTION IN MAN - KINETIC-ANALYSIS USING PERIPHERAL CONNECTING PEPTIDE BEHAVIOR [J].
EATON, RP ;
ALLEN, RC ;
SCHADE, DS ;
ERICKSON, KM ;
STANDEFER, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (03) :520-528